Plk-1

CAT # Inoa Huahana wehewehe
CPDB1974 GSK-461364 ʻO GSK461364 e hoʻopau i ka hoʻopaʻa ʻana i ke kaʻa uila i nā laina cell cancer proliferating like ʻole a, ma nā kiʻekiʻe kiʻekiʻe, hoʻoulu i ka apoptosis. ʻIke ʻia ʻoi aku ka maikaʻi e kūʻē i nā maʻi maʻi p53-deficient a hiki ke hele i ka pale koko-lolo. He mea maikaʻi ʻo GSK461364 i loko o ka vivo, e hoʻoulu ai i ka ulu ʻana o ka tumo a i ʻole ka lohi o ka ulu ʻana i nā hiʻohiʻona xenograft i nā ʻiole.
,

Kāhea iā mā˚ou

Ninau

Nuhou Hou

  • ʻO 7 ʻoi loa ma ka noiʻi lāʻau lapaʻau ma 2018

    ʻO 7 ʻoi loa i ka noiʻi lāʻau lapaʻau I...

    Ma lalo o ka piʻi nui ʻana o ka hoʻokūkū e hoʻokūkū i kahi ʻenehana paʻakikī a me ka ʻenehana, pono e hoʻomau nā ʻoihana lāʻau lapaʻau a me biotech i kā lākou papahana R&D e noho i mua ...

  • ARS-1620: He mea hoʻohiki hou no nā maʻi maʻi KRAS-mutant

    ARS-1620: He mea hoʻohiki hou no K...

    Wahi a kahi noiʻi i paʻi ʻia ma Cell, ua hoʻomohala nā mea noiʻi i kahi inhibitor kūikawā no KRASG12C i kapa ʻia ʻo ARS-1602 i hoʻoulu i ka regression tumor i nā ʻiole. "Ke hāʻawi nei kēia haʻawina i nā hōʻike vivo e hiki ke lilo i mutant KRAS ...

  • Loaʻa iā AstraZeneca ka hoʻoikaika kānāwai no nā lāʻau lapaʻau oncology

    Loaʻa iā AstraZeneca ka hoʻonui hoʻoponopono no...

    Ua loaʻa iā AstraZeneca kahi hoʻonui pālua no kāna kōpili oncology i ka Pōʻalua, ma hope o ka ʻae ʻana o nā regulators US a me ʻEulopa i nā hoʻouna kānāwai no kāna mau lāʻau lapaʻau, ʻo ka hana mua i ka lanakila ʻana i kēia mau lāʻau lapaʻau. ...

WhatsApp Online Chat !